Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Barreiro

Showing results (71-80 of 220) with videos related to

Pageof 22
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 18, 2021
Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in SpainIgnacio Barandalla, Carmen Alvarez, Pablo Barreiro, et al.
Current Opinion in Environmental Science & Health|September 30, 2020
Coronavirus and other airborne agents with pandemic potentialJose Vicente Fernandez-Montero, Vicente Soriano, Pablo Barreiro, et al.
Current Opinion in HIV and AIDS|April 18, 2009
Management and therapy of chronic hepatitis C in HIVVincent Soriano, Eugenia Vispo, Luz Martin-Carbonero, et al.
Expert Review of Anti-Infective Therapy|October 26, 2025
The cascade of care for hepatitis B - any lessons from the HIV field?Vicente Soriano, Víctor Moreno-Torres, Pablo Barreiro, et al.
AIDS Research and Human Retroviruses|February 26, 2009
Raltegravir and etravirine are active against HIV type 1 group OVerónica Briz, Carolina Garrido, Eva Poveda, et al.
Current HIV/AIDS Reports|May 31, 2008
Management of hepatitis B virus co-infection on and off antiretroviral therapyVincent Soriano, Eugenia Vispo, Marcelle Bottecchia, et al.
Therapeutic Advances in Infectious Disease|October 29, 2020
Advances in hepatitis B therapeuticsVicente Soriano, Pablo Barreiro, Edward Cachay, et al.
Journal of HIV Therapy|September 8, 2009
Hepatitis B in HIV patients: what is the current treatment and what are the challenges?Vincent Soriano, Paula Tuma, Eugenia Vispo, et al.
European Journal of Clinical Investigation|September 28, 2010
Elevated TGF-β1 levels might protect HCV/ HIV-coinfected patients from liver fibrosisNorma I Rallón, Pablo Barreiro, Vincent Soriano, et al.
Antiviral Therapy|November 6, 2014
Liver fibrosis progression despite HCV cure with antiviral therapy in HIV-HCV-coinfected patientsPablo Labarga, Jose V Fernandez-Montero, Carmen de Mendoza, et al.
Pageof 22

Showing results (71-80 of 220) with videos related to

Sort By:
Pageof 22
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 18, 2021
Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in SpainIgnacio Barandalla, Carmen Alvarez, Pablo Barreiro, et al.
Current Opinion in Environmental Science & Health|September 30, 2020
Coronavirus and other airborne agents with pandemic potentialJose Vicente Fernandez-Montero, Vicente Soriano, Pablo Barreiro, et al.
Current Opinion in HIV and AIDS|April 18, 2009
Management and therapy of chronic hepatitis C in HIVVincent Soriano, Eugenia Vispo, Luz Martin-Carbonero, et al.
Expert Review of Anti-Infective Therapy|October 26, 2025
The cascade of care for hepatitis B - any lessons from the HIV field?Vicente Soriano, Víctor Moreno-Torres, Pablo Barreiro, et al.
AIDS Research and Human Retroviruses|February 26, 2009
Raltegravir and etravirine are active against HIV type 1 group OVerónica Briz, Carolina Garrido, Eva Poveda, et al.
Current HIV/AIDS Reports|May 31, 2008
Management of hepatitis B virus co-infection on and off antiretroviral therapyVincent Soriano, Eugenia Vispo, Marcelle Bottecchia, et al.
Therapeutic Advances in Infectious Disease|October 29, 2020
Advances in hepatitis B therapeuticsVicente Soriano, Pablo Barreiro, Edward Cachay, et al.
Journal of HIV Therapy|September 8, 2009
Hepatitis B in HIV patients: what is the current treatment and what are the challenges?Vincent Soriano, Paula Tuma, Eugenia Vispo, et al.
European Journal of Clinical Investigation|September 28, 2010
Elevated TGF-β1 levels might protect HCV/ HIV-coinfected patients from liver fibrosisNorma I Rallón, Pablo Barreiro, Vincent Soriano, et al.
Antiviral Therapy|November 6, 2014
Liver fibrosis progression despite HCV cure with antiviral therapy in HIV-HCV-coinfected patientsPablo Labarga, Jose V Fernandez-Montero, Carmen de Mendoza, et al.
Pageof 22